Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,180,424 papers from all fields of science
Search
Sign In
Create Free Account
rivastigmine 1.5 MG Oral Capsule
Known as:
rivastigmine 1.5 MG (as rivastigmine tartrate 2.4 MG) Oral Capsule
, RIVASTIGMINE TARTRATE 1.5 mg ORAL CAPSULE [Rivastigmine Tartrate]
, RIVASTIGMINE TARTRATE 1.5MG CAP,UD
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
28 relations
1-Butanol
Alzheimer's Disease
Ammonia
Carbamates
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Novel Benzene-Based Carbamates for AChE/BChE Inhibition: Synthesis and Ligand/Structure-Oriented SAR Study
A. Bąk
,
V. Kozik
,
+8 authors
J. Jampílek
International Journal of Molecular Sciences
2019
Corpus ID: 91187746
A series of new benzene-based derivatives was designed, synthesized and comprehensively characterized. All of the tested…
Expand
2013
2013
Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients
M. Mäurer
,
S. Ortler
,
+4 authors
F. Tracik
Multiple Sclerosis
2013
Corpus ID: 6838286
Background: Cognitive decline has been recognised as a frequent symptom in multiple sclerosis (MS). Cholinesterase inhibitors…
Expand
2010
2010
[Oral galantamine versus rivastigmine transdermal patch: a descriptive study at a memory clinic in The Netherlands].
C. J. Wouters
,
L. Dautzenberg
,
A. Thissen
,
P. Dautzenberg
Tijdschrift voor Gerontologie en Geriatrie
2010
Corpus ID: 25145705
OBJECTIVES Since January 2008 in The Netherlands, two cholinesterase inhibitors, oral galantamine and rivastigmine transdermal…
Expand
2010
2010
Galantamine of rivastigmine pleister. Een beschrijvend onderzoek op een geheugenpolikliniek in Nederland
C. Wouters
,
L. Dautzenberg
,
A. Thissen
,
P. Dautzenberg
2010
Corpus ID: 68562744
SamenvattingDoel van onderzoek In Nederland zijn vanaf januari 2008 twee eenmaaldaags toe te dienen cholinesteraseremmers…
Expand
2007
2007
No significant effects of single intravenous, single oral and subchronic oral administration of acetylcholinesterase inhibitors on striatal [123I]FP-CIT binding in rats
R. Knol
,
K. Bruin
,
B. Eck-Smit
,
J. Booij
European Journal of Nuclear Medicine and…
2007
Corpus ID: 21529971
Purpose[123I]FP-CIT SPECT is a valuable diagnostic tool to discriminate Lewy body dementia from Alzheimer’s dementia. To date…
Expand
2003
2003
The clinical use of P300 event related potentials for the evaluation of cholinesterase inhibitors treatment in demented patients
E. Werber
,
R. Gandelman-Marton
,
C. Klein
,
J. Rabey
Journal of neural transmission
2003
Corpus ID: 24324706
Summary. Centrally acting cholinesterase inhibitors (ChEIs) improve cognitive functions in Alzheimer's disease (AD) and other…
Expand
2003
2003
PNM24 RIVASTIGMINE IS ASSOCIATED WITH SIGNIFICANTLY LESS CAREGIVER BURDEN THAN DONEPEZIL OR GALANTAMINE
E. Snyder
,
C. McBurney
,
Simu K. Thomas
,
S. Arcona
,
S. Bolge
2003
Corpus ID: 71417302
2001
2001
Evaluation of cholinergic treatment in demented patients by P300 evoked related potentials.
A. Werber
,
C. Klein
,
J. Rabey
Neurologia i Neurochirurgia Polska
2001
Corpus ID: 25018083
Centrally acting cholinesterase inhibitors (ChEls) improve cognitive functions in Alzheimer's disease (AD) and other forms of…
Expand
2001
2001
Novartis provides guidelines for reinitiating rivastigmine therapy
2001
Corpus ID: 195121149
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE